Balversa Tablet, Film Coated
Product Images NDC 59676-030

6 FDA label images from Janssen Products Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Balversa (NDC 59676-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Balversa 01)

Chemical Structure (Balversa 01)
Chemical structure of Erdafitinib, the active ingredient in BALVERSA tablets. The diagram displays the molecular formula with rings and functional groups corresponding to Erdafitinib's structure.*
FDA Label Image

Figure 1 (Balversa 02)

Figure 1 (Balversa 02)
Packaging label for Balversa (erdafitinib) tablets 3 mg, a prescription oral film-coated tablet by Janssen Products LP. The carton is primarily white with green and blue text. It includes the brand name, generic name, and strength prominently on several panels. Contains 56 film-coated tablets. Includes storage instructions, child-resistant packaging notice, and manufacturer detail (Product of Switzerland). Barcodes and NDC number 59676-030-56 are also visible.*
FDA Label Image

Figure 2 (Balversa 03)

Figure 2 (Balversa 03)
Packaging label for BALVERSA (erdafitinib) tablets 4 mg, oral film-coated tablets. The box is labeled for 56 film-coated tablets, manufactured by Janssen Products LP, Horsham, PA. It includes storage instructions, dosage recommendations, and states it is a child-resistant package. Product is identified as made in Switzerland with an NDC of 59676-040-56.*
FDA Label Image

3 mg Tablet Bottle Carton (Balversa 04)

3 mg Tablet Bottle Carton (Balversa 04)
Box label for BALVERSA (erdafitinib) 5 mg film-coated tablets. The label shows the product name, generic name, strength 5 mg, and dosage form as tablets. It states the product is manufactured by Janssen Products LP, Horsham, PA, and is a product of Switzerland. The box contains 28 film-coated tablets, with Rx only. Storage instructions and a caution about child resistance are also included.*
FDA Label Image

4 mg Tablet Bottle Carton (Balversa 05)

4 mg Tablet Bottle Carton (Balversa 05)
The packaging label for BALVERSA (erdafitinib) 4 mg film-coated tablets is shown. The carton indicates 56 tablets, Rx only, and features Janssen Products LP as the manufacturer. Storage temperature and child-resistant warnings are noted. The label includes product origin as Switzerland and barcodes on two sides.*
FDA Label Image

5 mg Tablet Bottle Carton (Balversa 06)

5 mg Tablet Bottle Carton (Balversa 06)
Balversa 5 mg (erdafitinib) tablets packaging label for oral administration. The label indicates 28 film-coated tablets per package, manufactured for Janssen Products LP. The label includes storage instructions, child-resistant packaging notice, and states the product is made in Switzerland. The label features a barcode and the Janssen logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.